Vitalay Fomin
New York
Founder & CEO

Vitalay Fomin

Data/Biomarker discovery scientist leveraging Real Word and clinical trial data to reveal mechanisms of drug resistance in immunotherapy driving efforts in patient enrichment strategies, biomarker discovery and reverse translation target discovery. In my previous role I used multiple biochemistry and molecular biology techniques to investigate molecular mechanisms/signaling cascades contributing to cancer progression. I am very passionate about combining my expertise in cancer biology with advanced computational tools to drive actionable biomarker and drug discovery efforts.
https://www.numenos.ai

Info about the founder

Data/Biomarker discovery scientist leveraging Real Word and clinical trial data to reveal mechanisms of drug resistance in immunotherapy driving efforts in patient enrichment strategies, biomarker discovery and reverse translation target discovery. In my previous role I used multiple biochemistry and molecular biology techniques to investigate molecular mechanisms/signaling cascades contributing to cancer progression. I am very passionate about combining my expertise in cancer biology with advanced computational tools to drive actionable biomarker and drug discovery efforts.

In The News

No items found.